As of Jan 20
| -6.26 / -11.28%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 63.50, with a high estimate of 86.00 and a low estimate of 44.20. The median estimate represents a +28.99% increase from the last price of 49.23.
The current consensus among 24 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.